Cargando…

Application of a Novel Curcumin Analog in the Management of Diabetic Cardiomyopathy

Detalles Bibliográficos
Autores principales:	Ren, Jun, Sowers, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171654/ https://www.ncbi.nlm.nih.gov/pubmed/25249640 http://dx.doi.org/10.2337/db14-0863

Ejemplares similares

Role of TRIB3 in Diabetic and Overnutrition-Induced Atherosclerosis
por: Sowers, James R.
Publicado: (2012)

Implications for Glucose Measures in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
por: Whaley-Connell, Adam, et al.
Publicado: (2014)

Glycogen Synthase Kinase-3β and Cathepsin B in Diabetic Endothelial Progenitor Cell Dysfunction: An Old Player Finds a New Partner
por: Muniyappa, Ranganath, et al.
Publicado: (2014)

Inhibition of HIV-1 by curcumin A, a novel curcumin analog
por: Kumari, Namita, et al.
Publicado: (2015)

Mineralocorticoid Receptors: An Appealing Target to Treat Coronary Microvascular Dysfunction in Diabetes
por: Bender, Shawn B., et al.
Publicado: (2015)

Role of Perivascular Adipose Tissue on Vascular Reactive Oxygen Species in Type 2 Diabetes: A Give-and-Take Relationship
por: Padilla, Jaume, et al.
Publicado: (2015)

Curcumin Alleviates Diabetic Cardiomyopathy in Experimental Diabetic Rats
por: Yu, Wei, et al.
Publicado: (2012)

Caveolin-1 in Cardiovascular Disease: A Double-Edged Sword
por: Jia, Guanghong, et al.
Publicado: (2015)

Diabetes and the Heart: Is There Objective Evidence of a Human Diabetic Cardiomyopathy?
por: Litwin, Sheldon E.
Publicado: (2013)

The curcumin analog EF24 is a novel senolytic agent
por: Li, Wen, et al.
Publicado: (2019)

New Thoughts in an Old Player: Role of Nitrite in the Treatment of Ischemic Revascularization
por: Jia, Guanghong, et al.
Publicado: (2014)

Interaction of Islet α-Cell and β-Cell in the Regulation of Glucose Homeostasis in HI/HA Syndrome Patients With the GDH(H454Y) Mutation
por: Jia, Guanghong, et al.
Publicado: (2014)

Endothelial Insulin and IGF-1 Receptors: When Yes Means NO
por: Muniyappa, Ranganath, et al.
Publicado: (2012)

Targeting CITED2 for Angiogenesis in Obesity and Insulin Resistance
por: Jia, Guanghong, et al.
Publicado: (2016)

Increased Fibro-Adipogenic Progenitors and Intramyocellular Lipid Accumulation in Obesity-Related Skeletal Muscle Dysfunction
por: Jia, Guanghong, et al.
Publicado: (2019)

Inflammation attenuating lncRNAs in diabetic cardiomyopathy
por: Mohsin, Sadia, et al.
Publicado: (2023)

Ghrelin: A New Incretin Enhancer Therapy?
por: DeMarco, Vincent G., et al.
Publicado: (2015)

Endothelium-Derived Hyperpolarizing Factors: A Potential Therapeutic Target for Vascular Dysfunction in Obesity and Insulin Resistance
por: Jia, Guanghong, et al.
Publicado: (2016)

Bioactivities of EF24, a Novel Curcumin Analog: A Review
por: He, Yonghan, et al.
Publicado: (2018)

Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer’s Disease
por: Gagliardi, Stella, et al.
Publicado: (2018)

Exosomes in Diabetic Cardiomyopathy: The Next-Generation Therapeutic Targets?
por: Sahoo, Susmita, et al.
Publicado: (2016)

Uncovering a Mineralocorticoid Receptor–Dependent Adipose–Vascular Axis: Implications for Vascular Dysfunction in Obesity?
por: Jia, Guanghong, et al.
Publicado: (2016)

Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action
por: Hill, Michael A., et al.
Publicado: (2021)

Curcumin Analogs Reduce Stress and Inflammation Indices in Experimental Models of Diabetes
por: Biswas, Saumik, et al.
Publicado: (2019)

Glucagon-Like Peptide 1 Receptor Activation and Platelet Function: Beyond Glycemic Control
por: Jia, Guanghong, et al.
Publicado: (2016)

The VASP Road to NAFLD: A Macrophage Detour
por: Lastra, Guido, et al.
Publicado: (2015)

Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy
por: Mimeault, Murielle, et al.
Publicado: (2011)

Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs
por: Pignanelli, Christopher, et al.
Publicado: (2017)

The role of curcumin in liver diseases
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2018)

Induced Resistance Mechanism of Novel Curcumin Analogs Bearing a Quinazoline Moiety to Plant Virus
por: Yin, Limin, et al.
Publicado: (2018)

Synthesis and Evaluation of a Series of Novel Asymmetrical Curcumin Analogs for the Treatment of Inflammation
por: Zhang, Yali, et al.
Publicado: (2014)

Curcumin Conjugated Gold Nanoclusters as Perspective Therapeutics for Diabetic Cardiomyopathy
por: Wei, Dong-zhuo, et al.
Publicado: (2021)

Interaction of Adipogenesis and Angiogenesis in Dietary-Induced Obesity
por: Jia, Guanghong, et al.
Publicado: (2015)

Targeting DNA Damage and Repair by Curcumin
por: Ji, Zhenyu
Publicado: (2010)

Cationic Anthraquinone Analogs as Selective Antimicrobials
por: Subedi, Yagya Prasad, et al.
Publicado: (2019)

Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury
por: Zhang, Yali, et al.
Publicado: (2015)

Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
por: Chang, Chia‐Hsuin, et al.
Publicado: (2017)

Curcumin: A Natural Multitarget Treatment for Pancreatic Cancer
por: Sahebkar, Amirhossein
Publicado: (2016)

Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro
por: Wu, Jianzhang, et al.
Publicado: (2015)

Autophagy and Apoptosis in Hepatocellular Carcinoma Induced by EF25-(GSH)(2): A Novel Curcumin Analog
por: Zhou, Tao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_eqnt56dqh0hrskjpa22lgm1skr